The Alliance for the Prevention of Colorectal Cancer in Spain. A civil commitment to society;Alianza para la Prevención del Cáncer de Colon en España: Un compromiso cívico con la sociedad

Gastroenterologia y Hepatologia

Volumn 35, Issue 3, 2012, Pages 109-128

  Morillas, Juan Diego ^a   Castells, Antoni ^a   Oriol, Isabel ^a   Pastor, Ana ^a   Pérez Segura, Pedro ^a   Echevarría, José Manuel ^a   Caballero, Begoña ^a   González Navarro, Andrés ^a   Bandrés, Fernando ^a   Brullet, Enric ^a   Iniesta, Antonio ^a   Carballo, Fernando ^a   Bouzas, Rosa ^a   Ariza, Aurelio ^a   Ibisate, Alfredo ^a   García Alfonso, Pilar ^a   Escudero, Beatriz ^a   Camacho, Silvia ^a   Fernández Marcos, Ana ^a   González, Teresa ^a   Quintero, Enrique ^a   Lanas, Ángel ^a   Marzo, Mercè ^a   Mascort, Juanjo ^a   Andréu, Monserrat ^a   Cerezo, Laura ^a   Vázquez Sequeiros, Enrique ^a   Borrás, Josep María ^a   Salas, Dolores ^a   Ascunce, Nieves ^a   Portillo, Isabel ^a   Herráiz, Mayte ^a   Valle, María Luisa ^a   Sotoca, Amalia ^a   Nieto, Santiago ^a   Hué, Carlos ^a   Paz Ares, Luis ^a   more..

^a NONE

Author keywords

Alliance; Colorectal cancer; CRC; Early detection; Prevention; Screening

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; CANCER STAGING; COLORECTAL CANCER; HUMAN; INFORMATION DISSEMINATION; MEDICAL SOCIETY; NON PROFIT ORGANIZATION; SPAIN;

COLONOSCOPY; COLORECTAL NEOPLASMS; COOPERATIVE BEHAVIOR; EARLY DETECTION OF CANCER; GOALS; HEALTH EDUCATION; HEALTH PRIORITIES; HEALTH PROMOTION; HUMANS; INCIDENCE; INFORMATION DISSEMINATION; MASS SCREENING; OCCULT BLOOD; ORGANIZATIONS; ORGANIZATIONS, NONPROFIT; PRACTICE GUIDELINES AS TOPIC; PRIVATE SECTOR; PUBLIC SECTOR; SELF-HELP GROUPS; SOCIETIES, MEDICAL; SOCIETIES, SCIENTIFIC; SPAIN; WORLD HEALTH;

EID: 84857995303     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2012.01.002     Document Type: Article

References (262)

1. INE. INEBASE. 2011. Defunciones según la causa de muerte 2009. INE.es. [consultado 9/12/2011]. Disponible en: http://www.ine.es/jaxi/menu.do%3Ftype=pcaxis%26path=/t15/p417/a2009/%26file=pcaxis.
2. INE. INEBASE. 2010. Defunciones según la causa de muerte 2008. INE.es. [consultado 9/12/2011]. Disponible en: http://www.ine.es/jaxi/menu.do%3Ftype=pcaxis%26file=pcaxis%26path=%2Ft15%2Fp417%2F%2Fa2008.
3. INE. INEBASE. Defunciones según la causa de muerte 1999. INE.es. [consultado 9/12/2011]. Disponible en: http://www.ine.es/jaxi/menu.do%3Ftype=pcaxis%26file=pcaxis%26path=%2Ft15%2Fp417%2F%2Fa1999.
4. Ferlay J., Parkin D.M., Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010, 46:765-781.
5. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC Cancer Base no. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Int J Cancer 2010;127:2893-2917.
6. Boyle P., Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005, 16:481-488.
7. Cabanes A., Pérez-Gómez B., Aragonés N., Pollán M., López-Abente G. La situación del cáncer en España, 1975-2006 2009, Instituto de Salud Carlos III, Madrid.
8. López-Abente G., Ardanaz E., Torrella-Ramos A., Mateos A., Delgado-Sanz C., Chirlaque M.D. Changes in colorectal cancer incidence and mortality trends in Spain. Ann Oncol 2010, 21(Suppl 3):S76-S82. for the Colorectal Cancer Working Group.
9. Sanchez M.J., Payer T., De Angelis R., Larrañaga N., Capocaccia R., Martínez C. Cancer incidente and mortality in Spain: estimates and projections for the period 1981-2012. Ann Oncol 2010, 21(Suppl 3):S30-S36. CIBERESP Working Group.
10. Encuesta de morbilidad hospitalaria 2010. INE. INEBASE. [consultado 10/12/2011]. Disponible en: http://www.ine.es/jaxi/menu.do%3Ftype=pcaxis%26file=pcaxis%26path=%2Ft15%2Fp414%2F%2Fa2010.
11. Karsa L.V., Lignini T.A., Patnick J., Lambert R., Sauvaget C. The dimensions of the CRC problem. Best Pract Res Clin Gastroenterol 2010, 24:381-396.
12. Center M.M., Jemal A., Smith R.A., Ward E. Worldwide Variations in Colorectal Cancer. CA Cancer J Clin 2009, 59:366-378.
13. Lieberman D.A. Screening for colorectal cancer. N Engl J Med 2009, 361:1179-1187.
14. Brawley O.W. Avoidable Cancer Deaths Globally. CA Cancer J Clin 2011, 61:67-68.
15. Siegel R., Ward E., Brawley O., Jemal A. Cancer Statistics, 2011 The Impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011, 61:212-236.
16. Castells A., Marzo M., Bellas B., Amador F.J., Lanas A., Mascort J.J., et al. Clinical guidelines for the prevention of colorectal cancer. Gastroenterol Hepatol 2004, 27:573-634.
17. Adán L., álvarez-Castro A., Castells A. An approximation to familial colorectal cancer. Gastroenterol Hepatol 2010, 33:652-659.
18. Lynch H.T., de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003, 348:919-932.
19. Balaguer F., Ocaña T., Garrell I., Ferrandez A. High risk clinics: a new concept in colon and rectum cancer prevention. Med Clin (Barc) 2008, 131:382-386.
20. Real Academia Española. Diccionario de la lengua española. Vigésima segunda edición. Disponible en: http://buscon.rae.es/draeI/SrvltConsulta%3FTIPO_BUS=3%26LEMA=cribar.
21. Joint Statement of Recommendations by the American Hospital Association, American Medical Association. American Public Health Association, and American Public Welfare Association. Am J Public Health Nations Health 1947, 37:1256-1266. Planning for the Chronically Ill.
22. Atwater R.M., Greenburg L., Mudd S., Henderson J.M., Patterson R.S., Muckenfuss R.S., et al. Commission on chronic illness. Am J Public Health Nations Health 1949, 39:1343-1344.
23. Wilson J.M.G., Junger G. Principles and practice of screening for disease 1968, World Health Organization, Geneve.
24. Holland W.W., Stewart S., Masseria C. Policy brief: screening in Europe. Geneva: World Health Organization. European Observatory on Health Systems and Policies 2006, Disponible en: http://www.euro.who.int/Document/E88698.pdf.
25. Levin M.L. Descubrimiento y exámenes de selección para cáncer. Medicina Preventiva 1962, 339-350. Editorial Interamericana, México. H.E. Hilleboe, G.W. Larimore (Eds.).
26. Morabia A., Zhang F.F. History of medical screening: from concepts to action. Postgrad Med J 2004, 80:463-469.
27. Volume I: Prevention of Chronic Illness. JAMA 1957, 165:1513. Chronic Illness in the United States.
28. Erickson C.C. Exfoliative cytology in mass screening for uterine cancer Memphis and Shelby County. Tennessee. CA A Cancer J Clin 1955, 5:63-64.
29. Shapiro S., Strax P., Veneto L. Evaluation of periodic breast cancer screening with mammography: methodology and early observations. JAMA 1966, 195:731-738.
30. Lehman E.P. What the nonspecialist should know about cancer of the rectum. CA A Cancer J Clin 1950, 1:79-83.
31. State D. Diagnosis of gastrointestinal cancer in the office of the general practitioner. CA A Cancer J Clin 1951, 1:120-122.
32. Cancer prevention and detection in the anus, rectum and colon. CA A Cancer J Clin 1958, 8:197-200. Progress in cancer detection: II.
33. Ortmayer M. Proctosigmoidoscopy: Its technique. CA A Cancer J Clin 1951, 1:189-194.
34. Knoernschild H.E. Sigmoidoscopic examination: routine use for patients in hospital. CA A Cancer J Clin 1966, 16:29-30.
35. Knight I.A. The value of routine sigmoidoscopic examination. CA A Cancer J Clin 1966, 16:232-236.
36. Rossini F.P. Atlas of Coloscopy 1975, Piccin Medical Books, Padova.
37. Greegor D.H. Diagnosis of large-bowel cancer in the asymptomatic patient. JAMA 1967, 201:943-945.
38. Day E. The cancer detection examination. CA A Cancer J Clin 1961, 11:103-106.
39. Clark T.W, Schor S.S., Elsom K.O., Hubbard J.P., Elsom K.A. The periodic health examination: evaluation of routine tests and procedures. Ann Intern Med 1961, 54:1209-1222.
40. Gilbertsen V.A., Wangensteen O.H. The results of efforts for asymptomatic diagnosis of cancer. CA A Cancer J Clin 1964, 14:155-157.
41. Illingworth D.G. The choice of occult blood test in general practice. J Coll Gen Pract 1965, 9:33-44.
42. Eger S.A. Early diagnosis in colon and rectal cancer. CA Cancer J Clin 1965, 15:273-275.
43. Greegor D.H. Detection of silent colon cancer in routine examination. CA Cancer J Clin 1969, 19:330-337.
44. Greegor D.H Detection of colorectal cancer using guaiac slides. CA Cancer J Clin 1969, 19:360-363.
45. Bolt R.J. Sigmoidoscopy in detection and diagnosis in the asymptomatic individual. Cancer 1971, 28:121-130.
46. Frame P.S., Carlson S.J. A critical review of periodic health screening using specific screening criteria. Part 2: Selected endocrine, metabolic and gastrointestinal diseases. J Fam Pract 1975, 2:123-129.
47. Rauscher F.J. The National Cancer Program Plan. CA A Cancer J Clin 1973, 23:47-51.
48. Leffall A.D. Early diagnosis of colorectal cancer. CA Cancer J Clin 1974, 24:152-159.
49. Miller S.F. Colorectal cancer: are the goals of early detection achieved?. CA Cancer J Clin 1977, 27:338-343.
50. Breslow L., Somers A.R. The Lifetime Health-Monitoring Program - A practical approach to preventive medicine. N Engl J Med 1977, 296:601-608.
51. Miller S.F. Colorectal cancer: are the goals of early detection achieved?. CA A Cancer J Clin 1977, 27:338-343.
52. Canadian Task Force on the periodic health examination. CMA Journal 1979, 121:1193-1254. The periodic health examination.
53. Kristein M.M. Part C: Medical Economics. Social Sci Med 1980, 14:275-284.
54. Winawer S.J. Screening for colorectal cancer: an overview. Cancer 1980, 45(Suppl 5):1093-1098.
55. Cancer of the colon and rectum. CA Cancer J Clin. 1980; 30: 208-15.
56. Screening for and staging of cancer: a statement by the american joint committee for cancer staging and end results reporting. CA Cancer J Clin. 1980; 30: 324-25.
57. Cancer of the colon and rectum: summary of a public attitude survey. CA Cancer J Clin 1983; 33: 359-65.
58. Programs and Projects. Cancer Screening and Early Detection of Cancer. 2008-2013 Action Plan for the Global Strategy for the Prevention and Control of non communicable diseases. WHO 2008, World Health Organisation, [consultado 10/12/2011]. Disponible en:. http://www.who.int/nmh/publications/9789241597418/en/index.html.
59. Winawer S.J., Sherlock P. Surveillance for colorectal cancer in average-risk patients, familial high-risk groups, and patients with adenomas. Cancer 1982, 50(Suppl 11):2609-2614.
60. Castells A. Prevención del cáncer colorrectal. Med Clin (Barc) 2001, 117:69-75.
61. Mandel J.S. Screening for colorectal cancer. Gastroenterol Clin N Am 2008, 337:97-115.
62. Preventive Services Task Force Recommendation Statement, U.S., Preventive Services Task, Force. Ann Intern Med 2008, 149:627-637. Screening for Colorectal Cancer:, U.S.
63. Atkin W.S., Edwards R., Kralj-Hans I., Wooldrage K., Hart A.R., Northover J.M.A., et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010, 375:1624-1633.
64. Hoerr S.O., Bliss W.R., Kauffman J. Clinical evaluation of various tests for occult blood in the faeces. JAMA 1949, 141:1217-1218.
65. Greegor D.H. A progress report. Detection of colorrectal cancer using guaiac slides. CA Cancer J Clin 1972, 22:360-363.
66. Craig D.G. Tests for occult blood. J R Coll Gen Pract 1975, 25:698-701.
67. Gilbertsen V.A., Church T.R., Grewe F.J., Mandel J.S., McHugh R.B., Schuman L.M., et al. The desing of a study to assess occult-blood screening for colon cancer. J Chronic Dis 1980, 33:107-114.
68. Winawer S.J., Fleisher M., Baldwin M., Sherlock P. Current status of fecal occult blood testing in screening for colorectal cancer. CA A Cancer J Clin 1982, 32:100-112.
69. Hardcastle J.D, Farrands P.A., Balfour T.W., Chamberlain J., Amar S.S., Sheldon M.G. Cotrolled trial of faecal occult blood testing in the detection of colorectal cancer. Lancet 1983, 8340:1-4.
70. Simon J.B. Occult Blood Screening for Colorectal Carcinoma: A Critical Review. Gastroenterology 1985, 88:820-837.
71. Mandel J.S., Bond J.H., Church T.R., Snover D.C., Bradley G.M., Schuman L.M., et al. Reducing mortality from colorrectal cancer by screening for fecal occult blood. N Engl J Med 1993, 328:1365-1371. Minnesota Colon Cancer Control Study.
72. Hardcastle J.D., Chamberlain J.O., Robinson M.H., Moss S.M., Amar S.S., Balfour T.W., et al. Randomised controlled trialof faecal- occult- blood screening for colorectal cancer. Lancet 1996, 348:1472-1477.
73. Kronborg O., Fenger C., Olsen J., Jorgensen O.D., Sondergaard O. Randomised study of screening for colorrectal cancer with faecal-occult blood test. Lancet 1996, 348:1467-1471.
74. Kewenter J., Brevinge H., Engaras B., Haglind E., Ahren C. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects. Scand J Gastroenterol 1994, 29:468-473.
75. Mandel J.S., Church T.R., Ederer F., Bond J.H. Colorectal cancer mortality: Effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999, 91:434-437.
76. Mandel J.S., Church T.R., Bond J.H., Ederer F., Geisser M.S., Mongin S.J., et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000, 343:1603-1607.
77. Scholefield J.H., Moss S., Sufi F., Mangham C.M., Hardcastle J.D. Effect of faecal occult blood screening on mortality from colorectal cancer: Results from a randomised controlled trial. Gut 2002, 50:840-844.
78. Lindholm E., Brevinge H., Haglind E. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg 2008, 95:1029-1036.
79. Kronborg O., Jorgensen O.D., Fenger C., Rasmussen M. Randomized study of bienal screening with a faecal occult blood test: Results alter nine screening rounds. Scand J Gastroenterol 2004, 39:846-851.
80. Faivre J., Dancourt V., Lejeune C., Tazi M.A., Lamour J., Gerard D., et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 2004, 126:1674-1680.
81. Heresbach D., Manfredi S., D'halluin P.N., Bretagne J.F., Branger B. Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test. Eur J Gastroenterol Hepatol 2006, 18:427-433.
82. Hewitson P., Glasziou P., Irwig L., Towler B., Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev 2007, 1:CD001216.
83. Hewitson P., Glasziou P., Watson E., Towler B., Irwig L. Cochrane Systematic Review of colorectal cancer screening using the fecal cccult blood test (Hemoccult): An Update. Am J Gastroenterol 2008, 103:1541-1549.
84. Turunen M.J., Liewendahl K., Partanen P., Adlercreutz H. Immunological detection of faecal occult blood in colorectal cancer. Br J Cancer 1984, 49:141-148.
85. Armitage N., Hardcastle J.D., Amar S.S., Balfour T.W., Haynes J., James P.D. A comparison of an immunological faecal occult blood test Fecatwin sensitive/FECA EIA with Haemoccult in population screening for colorectal cancer. Br J Cancer 1985, 51:799-804.
86. Hiwatashi N., Morimoto T., Fukao A., Sato H., Sugahara N., Hisamichi S., et al. An evaluation of mass screening using fecal occult blood test for colorectal cancer in Japan: a case-control study. Jpn J cancer Res 1993, 84:1110-1112.
87. Saito H. Colorectal cancer screening using immunochemical faecal occult blood testing in Japan. J Med Screen 2006, 13(Suppl 1):S6-S7.
88. Castiglione G., Sala P., Ciatto S., Grazzini G., Mazzotta A., Rossetti C., et al. Comparative analisis of results of guaiac and immunochemical tests for faecal occult blood in colorectal cancer screening in two oncological institutions. Eur J Cancer Prev 1994, 3:399-405.
89. Parra-Blanco A., Gimeno-Garcia A.Z., Quintero E., Nicolás D., Moreno S.G., Jiménez A., et al. Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening. J Gastroenterol 2009, 45:703-712.
90. Quintero E. ¿Test químico o test inmunológico para la detección de sangre oculta en heces en el cribado del cáncer colorrectal?. Gastroenterol Hepatol 2009, 32:565-576.
91. Van Rossum L.G., VanRijn A.F., Laheij A.F., VanOijen M.G., Fockens P., Van Krieken H.H., et al. Randon comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008, 135:82-90.
92. Corman M.L., Coller J.A., Veidenheimer M.C. Proctosigmoidoscopy age criteria for examination in the asymptomatic patient. CA A Cancer J Clin 1975, 25:2896-3289.
93. Newcomb P.A, Norfleet R.G., Storer B.E., Surawicz T.S., Marcus P.M. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992, 84:1572-1575.
94. Brenner H., Arndt V., Stürmer T., Stegmaier C., Ziegler H., Dhom G. Long-lasting reduction of risk of colorectal cancer following screening endoscopy. Br J Cancer 2001, 85:972-976.
95. Segnan N., Armarolli P., Bonelli L., Risio M., Sciallero S., Zappa M., et al. Once-Only Sigmoidoscopy in Colorectal Cancer Screening: Follow-up Findings of the Italian Randomized Controlled Trial-SCORE. J Natl Cancer Inst 2011, 103:1310-1322. the SCORE Working Group.
96. Díaz-Tasende J., Marín J.C. Utilidad de la sigmoidoscopia en el cribado del cáncer colorrectal en población con riesgo medio. Gastroenterol Hepatol Cont 2011, 10:187-190.
97. Gilbertsen V.A., Williams S.E., Schuman L., McHugh R. Colonoscopy in the detection of carcinoma of the intestine. Surg Gynecol Obstet 1979, 149:877-878.
98. Winawer S., Fletcher R., Rex D., Bond J., Burt R., Ferrucci J. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology 2003, 124:544-560. Gastrointestinal Consortium Panel.
99. Levin B., Murphy G.P. Revision in American Cancer Society recommendations for the early detection of colorectal cancer. CA A Cancer J Clin 1992, 42:296-299.
100. Winawer S.J, Zauber A.G., Ho M.N., O Brien M.J., Michael J., Gottlieb L.S., et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993, 329:1977-1981. The National Polyp Study Workgroup.
101. Winawer S., Zauber A.G., O Brien M.J., Ho M.N., Gottlieb L., Sternberg S.S., et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N Engl J Med 1993, 328:901-906. The The National Polyp Study Workgroup.
102. Müller A.D., Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. Ann Intern Med 1995, 123:904-910.
103. Kahi C.J., Imperiale T.F., Juliar B.E., Rex D.K. Effect of Screening Colonoscopy on Colorectal Cancer Incidence and Mortality. Clin Gastroenterol Hepatol 2009, 7:770-775.
104. Imperiale T.F., Wagner D.R., Lin C.Y., Larkin G.N., Rogge J.D., Ransohoff D.F. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000, 343:169-174.
105. Baxter N.N., Goldwasser M.A., Paszat L.F., Saskin R., Urbach D.R., Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009, 150:1-8.
106. Brenner H., Chang-Claude J., Seiler C.M., Rickert A., Hoffmeister M. Protection from colorectal cancer after colonoscopy. a population-based. Case-Control Study. Ann Intern Med 2011, 154:22-30.
107. Brenner H., Hoffmeister M., Arndt V., Stegmaier C., Altenhofen L., Haug U. Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst 2010, 102:89-95.
108. Castells A., Marzo-Castillejo M., Mascort J.J., Amador F.J., Andreu M., Bellas B., et al. Guia de Practica Clinica, Prevencion del Cancer Colorrectal. Actualización 2009. Gastroenterol Hepatol 2009, 32:717-758.
109. Piñol V., Andreu M., Castells A., Paya A., Bessa X., Rodrigo J. Frequency of hereditary non-polyposis colorectal cancer and other colorectal cancer familial forms in Spain: a multicentre, prospective, nationwide study. Eur J Gastroenterol Hepatol 2004, 16:39-45.
110. Colina F. Cáncer de mama, cáncer broncopulmonar y cáncer colorrectal. Incidencias observadas (1999-2007) y supervivencias. Registro de Tumores del Hospital Universitario 12 de Octubre de Madrid. 2008. [consultado 10/12/2011]. Disponible en: http://www.madrid.org/cs/Satellite?blobcol=urldata&blobheader=application%2Fpdf&blobheadername1=Content-disposition&blobheadername2=cadena&blobheadervalue1=filename%3Dcancer_mama_bronco_colorrectal.pdf&blobheadervalue2=language%3Des%26site%3DHospital12Octubre&blobkey=id&blobtable=MungoBlobs&blobwhere=1220685496638&ssbinary=true.
111. Chirlaque M.D., Salmerón D., Ardanaz E., Galcerán J., Martínez R., Marcos-Gragera R., et al. Cancer survival in Spain: estimate for nine major cancers. Ann Oncol 2010, 21(Suppl 3):S21-S29.
112. Sant M., Allemani C., Santaquilani M., Knijn A., Marchesi F., Capocaccia R., et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009, 45:931-991. EUROCARE Working Group.
113. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global Cancer Statistics. CA Cancer J Clin 2011, 61:69-90.
114. GLOBOCAN 2008. Cancer Incidence and Mortality Worldwide in 2008. International Agency for research on cancer. WHO. [consultado 10/12/2011]. Disponible en: http://globocan.iarc.fr/.
115. Castells A. Cribado del cáncer colorrectal. Gastroenterol Hepatol 2011, 34(Suppl 1):59-63.
116. Whitlock E.P., Lin J.S., Liles E., Beil T.L., Fu R. Screening for Colorectal Cancer: A Targeted. Updated Systematic Review for the U. S. Preventive Services Task Force. Ann Intern Med 2008, 149:638-658.
117. Borràs J.M., Espinàs J. Peris. Cribado poblacional del cáncer colorrectal: visión de la administración. Gastroenterol Hepatol Cont 2008, 7:252-256.
118. Alianza para la Prevención del Cáncer de Colon. [consultado 10/12/2011]. Disponible en: http://www.alianzaprevencioncolon.es/.
119. Castells A. Andreu M en representación del Grupo de Oncología Gastrointestinal de la Asociación Española de Gastroenterología. Proyecto EPICOLON: una contribución al conocimiento del síndrome de Lynch y otras formas hereditarias o familiares de cáncer colorrectal. Med Clin (Barc) 2007, 128:55-60.
120. Piqué J.M. New challenges in the training of the gastroenterologists of the future. Gastroenterol Hepatol 2009, 32:261-263.
121. El País. 4 de Diciembre de 2007. [consultado 10/12/2011]. Disponible en: http://www.elpais.com/articulo/salud/cribado/cancer/colon/elpepusocsal/20071204elpepisal_1/Tes.
122. Plan integral del cáncer. Detección precoz. Dirección General Agencia de Calidad 2003. [consultado 10/12/2011]. Disponible en: http://www.msc.es/Diseno/planes/Integrales/planes_integrales.htm.
123. Borràs J.M., Baselga J. The impact of cancer in Spain: consequences for cancer prevention and care. Ann Oncol 2010, 21(Suppl 3):S1-S2.
124. Borràs J.M., Colomer C., Soria P., López R. Priorities for cancer control in Spain. Ann Oncol 2010, 21(Suppl 3):S111-S114.
125. Ascunce N., Salas D., Zubizarreta D., Almazán R., Ibáñez J., Ederra M. Cancer screening in Spain. Ann Oncol 2010, 21(Suppl 3):S43-S51. representatives of the Network of Spanish Cancer Screening Programmes (Red de Programas Españoles de Cribado de Cáncer).
126. EIF's National Colorectal Cancer Research Alliance (NCCRA). [consultado 10/12/2011]. Disponible en: http://www.eifoundation.org/programs/eifs-national-colorectal-cancer-research-alliance.
127. Colon cancer Alliance. [consultado 10/12/2011]. Disponible en: http://www.ccalliance.org/.
128. Centers for disease control and prevention. [consultado 10/12/2011]. Disponible en: http://www.cdc.gov/.
129. NCCS. National coalition for cancer survivorship. [consultado 10/12/2011]. Disponible en: http://www.canceradvocacy.org/.
130. Fight colorectal cancer. [consultado 10/12/2011]. Disponible en: http://fightcolorectalcancer.org/.
131. Fédération Nationale des Comités Féminins pour la prévention et le dépistage des cancers. [consultado 10/12/2011]. Disponible en: http://www.comitesdepistagecancers.fr/.
132. The European Cancer Patient Coalition. [consultado 10/12/2011]. Disponible en: http://www.ecpc-online.org/.
133. IDCA. The International Digestive Cancer Alliance. [consultado 10/12/2011]. Disponible en: http://www.worldgastroenterology.org/assets/downloads/pdf/idca/publ/wgn_idca_series.pdf.
134. The Alliance for Global Cancer Control. World Health Organization (WHO). [consultado 10/12/2011]. Disponible en: http://www.who.int/mediacentre/news/releases/2003/pr61/en/index.html.
135. Union for International Cancer Control. [consultado 10/12/2011]. Disponible en http://www.uicc.org/.
136. Sarfaty M., Wender R., Smith R. Promoting cancer screening within the patient centered medical home. CA Cancer J Clin 2011, 61:397-408.
137. Ramsey S.D., Mandelson M.T., Berry K., Etzioni R., Harrison R. Cancer-attributable cost of diagnosis an care for persons with screen-detected symptom-detected colorrectal cancer. Gastroenterology 2003, 125:1645-1650.
138. Bailar J., Gornik H.L. Cancer undefeated. N Engl J Med 1997, 336:1569-1574.
139. La profesión médica en el nuevo milenio: estatutos para la regulación de la práctica médica. Med Clin (Barc) 2002; 118:704-706.
140. Sahuquillo MR. El País, 10 de noviembre de 2011. [consultado 12/12/2011]. Disponible en: http://www.elpais.com/articulo/sociedad/gasto/farmaceutico/hospitalario/crece/55/anos/elpepisoc/20111110elpepisoc_3/Tes.
141. Lansdorp-Vogelaar I., van Ballegooijen M., Zauber A.G., Habbema J.D.F., Kuipers E.J. Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. J Natl Cancer Inst 2009, 101:1412-1422.
142. INE. INEBASE. Cifras oficiales de población resultantes de la revisión del Padrón municipal a 1 de enero de 2011. Instituto Nacional de Estadística 2011. [consultado 12/12/2011]. Disponible en http://www.ine.es/jaxi/tabla.do.
143. Vicéns J. Anuario Económico de España 2011. Selección de indicadores. Estudios y análisis económicos. La Caixa. [consultado 12/12/2011]. Disponible en: http://www.lacaixa.es/estudios.
144. Abellán A, Esparza C. Un perfil de las personas mayores en España, 2011. Indicadores estadísticos básicos. Madrid, Informes Portal Mayores, n.° 127 [actualizado 28/10/2011]. Disponible en: http://www.imsersomayores.csic.es/documentos/documentos/pm-indicadoresbasicos11.pdf.
145. INE. INEBASE /Demografía y población /Cifras de población y Censos demográficos. 2021-2049: Proyecciones de la población a largo plazo. [consultado 12/12/2011]. Disponible en: http://www.ine.es/jaxi/menu.do%3Ftype=pcaxis%26path=%2Ft20%2Fp251%26file=inebase%26L=0.
146. Europe in figures-Eurostat yearbook 2010. [consultado 13/12/2011]. Disponible en: http://ec.europa.eu/eurostat.
147. Marcella S., Miller J.E. Racial differences in colorectal cancer mortality: the importance os stage and socioeconomic status. J Clin Epidemiol 2001, 54:359-366.
148. Andersen R., Newman J.F. Societal and Individual Determinants of Medical Care Utilization in the United States. Milbank Q 2005, 83:1-28.
149. Partridge E.E., Spencer E.B. Elimination of Cancer Disparities via Organizational Transformation and Community-Driven Approaches. CA Cancer J Clin 2011, 61:5-7.
150. Hernández V., Cubiella J., Iglesias F., Cid E. Participación en programas de cribado de cáncer colorrectal: ¿qué factores influyen?. Gastroenterol Hepatol Cont 2011, 10:87-90.
151. INE. INEBASE: Sociedad. Análisis Sociales. Indicadores Sociales 2009. Edición 2010. Cohesión y participación social. [consultado 13/12/2011]. Disponible en: http://www.ine.es/daco/daco42/sociales10/sociales.htmhttp%3A//www.ncbi.nlm.nih.gov/pubmed/10930794.
152. Bruguera M. La información de los avances científicos en la prensa. ¿es útil o más bien confunde?. Gastroenterol Hepatol Cont 2010, 9:150-153.
153. Colorectal cancer: not an embarrasing problem. Lancet. 2005; 366: 521.
154. Sala M., Castells A., Bessa X., Gargallo L., Piqué J.M. Screening for colorectal cancer in Catalonia. Results of a population survey. Gastroenterol Hepatol 1998, 9:427-431.
155. Cambas N. Conocimiento y percepción del cribado del cáncer colorrectal en la población española En: Cribado del cáncer de colon en España. ¿Es coste eficaz? 2011, Alianza para la prevención del cáncer de colon en España;, Madrid.
156. Andreu M., Marzo M., Mascort J., Quintero E., García-Alfonso P., López-Ibor C., et al. Prevención del cáncer colorrectal [editorial]. Gastroenterol Hepatol 2009, 32:137-139. en representación de la Alianza para la Prevención del Cáncer de Colon en España.
157. Calle E.E., Rodriguez C., Walker-Thurmond K., Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003, 348:1625-1638.
158. Chan A.T., Giovannucci E.L. Primary prevention of colorectal cancer. Gastroenterology 2010, 138:2029-2043.
159. Schütze M., Boeing H., Pischon T., Rehm J., Kehoe T., Gmel G. Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study. BMJ 2011, 342:d1584. Disponible en: http://www.bmj.com/content/342/bmj.d1584?tab.
160. Martínez F., Fernández-Martos C., Quintana M.J., Castells A., Llombart A., Iñiguez F., et al. APC and KRAS mutations in distal colorectal polyps are related to smoking habits in men: results of a cross-sectional study. Clin Transl Oncol 2011, 13:664-671.
161. Marzo M., Bellas B., Menús E., Ruin M., Vela C., Villarrubí M. Prevención del Cáncer Colorrectal. Rev Clin Med Fam 2010, 3:63-64. Grupo de Prevención del Cáncer del PAPPS de semFYC.
162. Byers T., Levin B., Rothenberger D., Dodd G.D., Smith R.A. American Cancer Society Guidelines for Screening and Surveillance for Early Detection of Colorectal Polyps and Cancer: Update 1997. CA A Câncer J Clin 1997, 47:154-160.
163. Lieberman D.A., Weiss D.G., Bond J.H., Ahnen D.J., Garewal H., Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 2000, 343:162-168.
164. U. S. Preventive Services Task Force. Ann Intern Med 2002, 137:129-131. Screening for Colorectal Cancer: Recommendation, Rationale.
165. Pignone M., Rich M., Teutsch S.M., Berg A.O., Lohr K.N. Screening for Colorectal Cancer in Adults at Average Risk: A Summary of the Evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002, 137:132-141.
166. Young G.P., St John D.J., Winawer S.J., Rozen P. Choice of fecal occult blood tests for colorrectal cancer screening: Recommendations based on performance characteristics in population studies: AWHO (World Health Organization) and WODE (World Organization for Digestive Endoscopy) report. Am J Gastroenterol 2002, 97:2499-2507.
167. Winawer S.J., Zauber A.G., Fletcher R.H., Stillman J.S., O'Brien M.J., Levin B., et al. Guidelines for Colonoscopy Surveillance After Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 2006, 130:1872-1885.
168. Levin B., Lieberman D.A., McFarland B., Andrews K.S., Brooks D., Bond J., et al. Screening and surveillance for early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008, 134:1570-1595.
169. Levin B., Lieberman D.A., McFarland B., Smith R.A., Brooks D., Andrews K.S., et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008, 58:130-160.
170. Whitlock E.P., Lin J.S., Liles E., Beil T.L., Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2008, 149:638-658.
171. Lieberman D.A. Progress and challenges in colorectal cancer screening and surveillance. Gastroenterology 2010, 138:2115-2126.
172. Smith R.A., Cokkinides V., Brooks D., Saslow D., Shah M., Brawley O.W. Cancer Screening in the United States, 2011. A Review of Current American Cancer Society Guidelines and Issues in Cancer Screening. CA Cancer J Clin 2011, 61:8-30.
173. Resolución del Consejo y de los Representantes de los gobiernos de los Estados miembros, reunidos en el seno del Consejo, de 7 de julio de 1986, referente a un programa de acción de las Comunidades Europeas contra el cáncer, DO C 184 de 23.7.1986. p. 19.
174. Decisión del Consejo y de los representantes de los gobiernos de los Estados miembros, reunidos en el seno del Consejo, de 21 de junio de 1988, por la que se adopta un plan de acción 1988-1989 relativo a una campaña de información y sensibilización en el marco del programa «Europa contra el Cáncer» (88/351/CEE), DO L 160 de 28.6.1988, p. 52.
175. Consejo de Europa: Comité de Ministros. On screening as a tool of preventive medicine, Recomendación n.° R. (94) 11. Estrasburgo: Consejo de Europa; 1994.
176. Recommendation to include colorectal cancer screening in public health policy. J Med Screen 1999, 6:80-81. European Group for Colorectal Screening.
177. Recommendations on cancer screening in the European Union. Eur J Cancer 2000, 36:1473-1478. Advisory Committee on Cancer Prevention.
178. Arbyn M., Van Oyen H., Lynge E., Micksche M. European consensus on cancer screening should be applied urgently by health ministers. BMJ 2001, 323:396.
179. Comisión de la Comunidad Europea. Propuesta de Recomendación del Consejo sobre cribado del cáncer. Bruselas, 5.5.2003. Volume 2003/878/CE, 2003:L327/34-L327/37. [consultado 13/12/2011]. Disponible en: http://ec.europa.eu/health/ph_determinants/genetics/documents/com_2003_0230_es.pdf.
180. The Council of the European Union, 2003. L 327/34 Official Journal of the European Union 16.12.2003. Council recommendation of 2 December 2003 on cancer screening (2003/878/EC). [consultado 13/12/2011]. Disponible en: :L: 2003:327:0034:0038:EN:PDF. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do%3Furi=OJ.
181. Europe against Colorectal Cancer: Declaration of Brussels (2007). [consultado 13/12/2011]. Disponible en: http://www.future-health-2007.com/.
182. First Report on the Implementation of the Council Recommendation on cancer screening. Internacional Agency for Research on Cancer 2008. Unión Europea. European Commission. Public Heath. [consultado 13/12/2011].. Disponible en: http://ec.europa.eu/health/ph_determinants/genetics/keydo_genetics_en.htm.
183. O'Morain C.A., Van Cutsem E., Spicakc J., Classend M., Woode L.F., Stockbruggerf R. European initiatives in colorectal cancer screening. Eur J Gastroenterol Hepatol 2011, 23:201-203.
184. Segnan N, Patnick J, von Karsa L, editors. European guidelines for quality assurance in colorectal cancer screening and diagnosis. Brussels: European Commission; 2011. [consultado 13/12/2011]. Disponible en: http://bookshop.europa.eu/is-bin/INTERSHOP.enfinity/WFS/EU-Bookshop-Site/en_GB/-/EUR/ViewPublication-Start%3FPublicationKey=ND3210390.
185. Cortés F., Artal F., Garcés A., Izcara J., Lacasa E., Zubiri F. Câncer colorrectal: detección mediante la prueba del guayaco en un centro de atención primaria. Med Clin (Barc) 1992, 98:325-328.
186. García A., Carballo F., De la Morena J. Aplicabilidad de programas de screening para cáncer colorrectal basados en el test de hemorragias ocultas en heces. Rev ACAD 1993, IX:40-41.
187. Tárraga P.J., Marín E., Celada A., García-Molinero M.J., García-Olmo D., Solera J. Evaluación económica del cáncer colorrectal mediante detección de sangre oculta en heces. Rev Esp Enf Dig 2000, 92:334-341.
188. Peris M., Espinàs J.A., Muñoz L., Navarro M., Binefa G., Borràs J.M. Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain). J Med Screening 2007, 14:81-86.
189. Málaga A., Salas D., Sala T., Ponce M., Goicoechea M., Andrés M., et al. Programa de cribado del cáncer colorrectal de la Comunidad Valenciana. Resultados de la primera ronda: 2005-2008. Rev Esp Salud Pública 2010, 84:729-741. Grupo Cribado de Cáncer Colorrectal de la Comunidad Valenciana.
190. Pérez-Riquelme F., Cruzado J., Carballo L.F., Torrella E.A., Lázaro M.D., Cavas M.C., et al. Prevención del cáncer de colon y recto en la Región de Murcia. Proyecto Piloto. La prevención del cáncer de colon y recto en la Región de Murcia 2008, Consejería de Sanidad de la Región de Murcia, Murcia, Serie Informes No: 50. F. Pérez-Riquelme, J. Cruzado Quevedo, J.J. Gutierrez-García (Eds.).
191. Castells X, Sala M, Ascunce N, Salas D, Zubizarreta R, Casamitjana M. Descripción del cribado del cáncer en España. Proyecto DESCRIC. Madrid: Plan de Calidad para el Sistema Nacional de Salud, Ministerio de Sanidad y Consumo, Agència d'Avaluacioó de Tecnología i Recerca Mediques de Catalunya; 2007. Informes de Evaluación de Tecnologias Sanitarias, AATRM núm. 2006/01.
192. Díaz-Rubio E., Ascunce N., Borràs J.M., Expósito J., Guillén V., López-Ibor B., et al. Estrategia contra el cáncer 2004, Ministerio de Sanidad y Consumo, Madrid.
193. Estrategia en cáncer del Sistema Nacional de Salud. Madrid: Ministerio de Sanidad y Consumo; 2006.
194. Recomendaciones del panel nacional de expertos para la planificación y puesta en marcha de programas organizados de base demográfica para la prevención del cáncer de colon y recto. Murcia: Consejería de Sanidad y Consumo, Dirección General de Salud Pública, Servicio de Promoción y Educación para la Salud, Región de Murcia, 2007.
195. Programa de detección precoz del cáncer colorrectal en Euskadi. Servicio Vasco de Salud. Osakidetza. [consultado 13/12/2011]. Disponible en: http://www.osakidetza.euskadi.net/r85-ckenfe10/es/contenidos/informacion/cancer_colorrectal/es_ccr/cancer_colorrectal.html.
196. Portillo I. Cribado de cáncer colorrectal en la comunidad autónoma del País Vasco. En: Prevención del cáncer de colon en España: un reto común. Madrid: Alianza para la prevención del cáncer de colon; 2010. [consultado 13/12/2011]. Disponible en: http://www.aeemt.com/contenidos_socios/Recursos/Documentos_interes/DOCUMENTO_PREVENCION_CANCER_COLON_20101020.pdf.
197. González de Aledo A. Situación actual del cribado de cancer colorrectal en Cantabria. En: Prevención del cáncer de colon en España: un reto común. Madrid: Alianza para la prevención del cáncer de colon; 2010. [consultado 13/12/2011]. Disponible en: http://www.aeemt.com/contenidos_socios/Recursos/Documentos_interes/DOCUMENTO_PREVENCION_CANCER_COLON_20101020.pdf.
198. Reyes J. Situación actual del cribado de cancer colorrectal en Canarias. En: Prevención del cáncer de colon en España: un reto común. Madrid: Alianza para la prevención del cáncer de colon; 2010. [consultado 13/12/2011]. Disponible en: http://www.aeemt.com/contenidos_socios/Recursos/Documentos_interes/DOCUMENTO_PREVENCION_CANCER_COLON_20101020.pdf.
199. Camacho S, Fernández A, González T, Pastor A, Pérez-Segura P, Diego Morillas J. Barreras para la implantación del cribado en España. Madrid: Alianza para la prevención del cáncer de colon en España; 2011. [consultado 15/12/2011]. Disponible en: https://www.aecc.es/Comunicacion/publicaciones/Documents/Barreras_en_la_implantaci%25C3%25B3n_cancercolon_def.pdf.
200. Estrategia en Cáncer del Sistema Nacional de Salud. Actualización 2009. Madrid, Ministerio de Sanidad y Política Social. [consultado 15/12/2011]. Disponible en: http://www.msps.es/organizacion/sns/planCalidadSNS/pdf/ActualizacionEstrategiaCancer.pdf.
201. Documento marco sobre cribado poblacional. Ministerio de Sanidad y Política Social 2011, Grupo de trabajo de la Ponencia de Cribado de la Comisión de Salud Pública, [consultado 15/12/2011]. Disponible en: http://www.msc.es/profesionales/saludPublica/prevPromocion/docs/Cribado_poblacional.pdf.
202. Red de programas españoles de cribado de cáncer. [consultado 15/12/2011]. Disponible en: http://www.cribadocancer.org/.
203. Castells X., Sala M., Salas D., Ascunce N., Zubizarreta R., Casamitjana M. Reflexiones sobre las prácticas de diagnóstico precoz del cáncer en España. Gac Sanit 2009, 23:244-249.
204. Salas D. Cribado del cáncer colorrectal: Fortalezas para avanzar en el cribado en España. Gac Sanit 2011, 25:329-330.
205. Programa de detección precoz de cáncer de mama. Premio a la calidad en el ámbito del Sistema Nacional de Salud. Instituto de Salud Pública de Navarra. [consultado 15/12/2011]. Disponible en: http://www.navarra.es/NR/rdonlyres/4C857D9C-1B17-49AE-BD7B-13F7AA5E1EAD/171933/DossierprensaPrograma.pdf.
206. INE. INEBASE. Profesionales sanitarios colegiados 2010. [consultado 15/12/2011]. Disponible en: http://www.ine.es/jaxi/tabla.do%3Fpath=/t15/p416/a2010/l0/%26file=s1001.px%26type=pcaxis%26L=0.
207. Barómetro Sanitario. Madrid: Instituto de Información Sanitaria, Ministerio de Sanidad, Política Social e Igualdad; 2010. [consultado 15/12/2011]. Disponible en: http://www.mspsi.gob.es/estadEstudios/estadisticas/sisInfSanSNS/informeAnual.htm.
208. En: Prevención del cáncer de colon en España: un reto común. Madrid: Alianza para la prevención del cáncer de colon; 2010. [consultado 13/12/2011]. Disponible en: http://www.aeemt.com/contenidos_socios/Recursos/Documentos_interes/DOCUMENTO_PREVENCION_CANCER_COLON_20101020.pdf.
209. Bandrés F, Castells A, Morillas JD. La prevención del cáncer colorrectal en España. Alianza para la prevención del cáncer de colon. Colección docencia universitaria. Madrid: Fundación Tejerina; 2009.
210. Navarro C.C., Martos C., Ardanaz E., Galceran J., Izarzugaza I., Peris-Bonet R., et al. Population-based cancer registries in Spain and their role in cancer control. Ann Oncol 2010, 21(Suppl. 3):S3-S13. for the Spanish Cancer Registries Working Group.
211. Ministerio de sanidad y Seguridad Social. Análisis de la situación sanitaria española. Madrid: Ministerio de sanidad y Seguridad Social, Subsecretaría de la salud; 1977.
212. Guía de práctica clínica de calidad en la colonoscopia de cribado del cáncer colorrectal 2011, Asociación Española de Gastroenterología y Sociedad Española de Endoscopia Digestiva, EDIMSA, Barcelona.
213. Lieberman D. A call to action - measuring the quality of colonoscopy. N Engl J Med 2006, 355:2588-2589.
214. Benson V.S., Patnick J., Davies A.K., Nadel M.R., Smith R.A., Atkin W.S. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer 2008, 122:1357-1367.
215. Joseph D.A., Rim S.H., Seeff L.C. Use of colorectal cancer tests-United States, 2002, 2004, and 2006. MMWR 2008, 57:253-258.
216. Rim S.H., Joseph D.A., Steele C.B., Thompson T.D., Seeff L.C. Colorectal Cancer Screening, Incidence, and Mortality - United States, 2002-2010. MMWR 2011, 60(Suppl 1):S42-S46.
217. Seeff L.C., DeGroff A., Tangka F., Wanliss E., Major A., Nadel M., et al. Development of a federally funded demonstration colorectal cancer screening program. Prev Chronic Dis 2008, 5:1-7. http://www.cdc.gov/pcd/issues/2008/apr/07_0206.htm.
218. Subramanian S., Tangka F.K., Hoover S., Degroff A., Royalty J., Seeff L.C. Clinical and programmatic costs of implementing colorectal cancer screening: evaluation of five programs. Eval Program Plann 2011, 34:147-153.
219. International Cancer Screening Network. Inventory of Colorectal Cancer Screening Activities in ICSN Countries, May 2008. US National Institutes of Health. Disponible en: http://www.cdc.gov/mmwr/pdf/other/su6001.pdf.
220. Screening subcommittee. Australian Health Ministers' Council 2008, Australian population health development principal committee, Disponible en: http://www.health.gov.au/internet/screening/publishing.nsf/Content/pop-based-screeningfwork/$File/screening-framework.pdf.
221. Grau J., Serradesanferm A., Polbach S., García-Basteiro A., Trilla A., Castells A. Programas de cribado del cáncer colorrectal en la población de riesgo medio en la Unión Europea y España. Gastroenterol Hepatol 2010, 33:111-118.
222. Karsa Lv, Anttila A, Ronco G, Ponti A, Malila N, Arbyn M, et al. European Commission, IARC, ECN and EUNICE; IDCA/IARC/UEGF Survey 11/2009. [consultado 16/12/2011]. Disponible en: http://appliedresearch.cancer.gov/icsn/meetings/2010/icsn2010_reports_von_karsa.pdf.
223. Karsa Lv, Anttila A., Ronco G., Ponti A., Malila N., Arbyn M., et al. Cancer screening in the European Union - Report on the implementation of the Council recommendation on cancer screening. First Report 2008, European Commission, Luxembourg.
224. Kanavos P., Schurer W., Owusuapenten C., Sullivan R. Colorrectal cancer in Europe and Australia: challenges and opportunities for the future. London School of Economics Health 2008.
225. Kanavos P., Schurer W., Owusuapenten C., Sullivan R. Colorectal cancer in Europe and Australia. Challenges and opportunities for the future. London Schools Economics. LSE HEALTH 2008, [consultado 16/12/2011]. Disponible en: http://www.tumori.net/it2/brochures/documenti/ColorectalCancerReport.pdf.
226. Kanavos P., Schurer W. The dynamics of colorectal cancer management in 17 countries. Eur J Health Econ 2010, 10(Suppl 1):S115-S129.
227. Schurer W., Kanavos P. Colorectal cancer management in the United Kingdom: current practice and challenges. Eur J Health Econ 2010, 10(Suppl 1):S85-S90.
228. NHS Bowel Cancer Screening Programme. [consultado 16/12/2011]. Disponible en: http://www.cancerscreening.nhs.uk/bowel/flexible-sigmoidoscopy-screening.html.
229. A national colorectal cancer screening programme 2009, Health Council of the Netherlands, Health Council of the Netherlands, The Hague, publication no. 2009/13E. [consultado 16/12/2011]. Disponible en: www.healthcouncil.nl.
230. Schurer W. The status of colorectal cancer care in the Netherlands: past, present and future. Eur J Health Econ 2010, 10(Suppl 1):S51-S56.
231. Goulard H., Boussac-Zarebska M., Ancelle-Park R., Bloch J. French colorectal cancer screening pilot programme: results of the first round. J Med Screen 2008, 15:143-148.
232. Chevreul K. Colorectal cancer in France. Eur J Health Econ 2010, 10(Suppl 1):S15-S20.
233. INCa 2010. La situation du cancer en France en 2010. Collection Rapports et synthèses. Institut National du Cancer, Boulogne-Billancourt, novembre 2010, 67 p. [consultado 16/12/2011]. Disponible en: http://www.e-cancer.fr/.
234. Hospices civils de Lyon /Institut de veille sanitaire /Institut national du cancer /Francim /Institut national de la santé et de la recherche médicale. Projections de l'incidence et de la mortalité par cancer en France en 2010. InVS. Avril 2010. 75 p. [consultado 16/12/2011]. Disponible en: http://www.invs.sante.fr/applications/cancers/projections2010/rapport_projections_nationales_cancer_2010.pdf.
235. Ministère de la Santé. Dossier de presse Mars Bleu 2011. France. [consultado 16/12/2011]. Disponible en: http://www.invs.sante.fr/surveillance/cancers_depistage/evalution_colorectal_programme.htm.
236. Masseria C. Colorectal cancer in Italy: a review of current national and regional practice on screening and treatment. Eur J Health Econ 2010, 10(Suppl 1):S41-S49.
237. Senore C., Armaroli P., Silvani M., Andreoni B., Bisanti L., Marai L., et al. Comparing different strategies for colorectal cancer screening in Italy: predictors of patients participation. Am J Gastroenterol 2010, 105:188-198.
238. Sieg A., Friedrich K. Perspectives of colorectal cancer screening in Germany 2009. World J Gastrointest Endosc 2009, 15:12-16.
239. Von der Schulenburg J.M., Prenzler A., Schurer W. Cancer management and reimbursement aspects in Germany: an overview demonstrated by the case of colorectal cancer. Eur J Health Econ 2010, 10(Suppl 1):S21-S26.
240. Ruszkowski J. Colorectal cancer management in Poland: current improvements and future challenges. Eur J Health Econ 2010, 10(Suppl 1):S57-S63.
241. Pinto C.G., Paquete A.T., Pissarra I. Colorectal cancer in Portugal. Eur J Health Econ 2010, 10(Suppl 1):S65-S73.
242. Boncz I., Brodszky V., Péntek M., ágoston I., Nagy Z., Kárpáti K. The disease burden of colorectal cancer in Hungary. Eur J Health Econ 2010, 10(Suppl 1):S35-S40.
243. Declaración por escrito sobre la lucha contra el cáncer colorrectal en la Unión Europea 0068/2010. [consultado 16/12/2011]. Disponible en: http://www.europarl.europa.eu/sides/getDoc.do%3Ftype=WDECL%26reference=P7-DCL-2010-0068%26language=ES%26format=PDF.
244. Balmaña J., Castells A., Cervantes A. Familial colorectal cancer risk: ESMO Clinical Practice Guidelines. Ann Oncol 2010, 21(Suppl. 5):v78-v81. On behalf of the ESMO Guidelines Working Group.
245. Lynch H.T., Lynch P.M., Albano W.A., Edney J., Organ C.H., Lynch J.F. Hereditary cancer: ascertainment and management. CA A Cancer J Clin 1979, 29:216-232.
246. Vasen H.F.A, Möslein G., Alonso A., Aretz S., Bernstein I., Bertario L., et al. Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Fam Cancer 2010, 9:109-115.
247. Castells A., Castellvi-Bel S., Balaguer F. Concepts in familial colorectal cancer: Where do we stand and what is the future?. Gastroenterology 2009, 137:404-409.
248. Weitzel J.N., Blazer K.R., MacDonald D.J., Culver J.O., Offit K. Genetics, Genomics, and Cancer Risk Assessment State of the Art and Future Directions in the Era of Personalized Medicine. CA Cancer J Clin 2011, 61:327-359.
249. Transatlantic Declaration, New York (2009). [consultado 16/12/2011]. Disponible en: http://www.felix-burda-stiftung.de/international-declarations/2009-new-york/index.php.
250. The Barcelona Declaration (2010). [consultado 16/12/2011]. Disponible en: http://www.felix-burda-stiftung.de/international-declarations/2010-barcelona/index.php.
251. Pérez-Segura P, Balaguer F. Need to implement a coordinated and multidisciplinary care in the Spanish population at increased risk for colorectal cancer. 2012. En prensa..
252. Rodríguez-Moranta F., Trapero-Bertrán M., Castells A., Mas-Canal X., Balaguer F., Pellisé M., et al. Endoscopic requirements of colorectal cancer screening programs in average-risk population. Estimation according to a Markov Model. Gastroenterol Hepatol 2008, 31:405-412.
253. Gimeno-García A.Z., Quintero E., Nicolás-Pérez D., Jiménez-Sosa A. Public awareness of colorectal cancer and screening in a Spanish population. Public Health 2011, 125:609-615.
254. Sonnenberg A., Delco F., Inadomi J.M. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 2000, 133:573-584.
255. Cohen J.T., Neumann P.J., Weinstein M.C. Does preventive care save money? Health economics and the presidential candidates. N Engl J Med 2009, 358:661-663.
256. Lansdorp-Vogelaar I., Knudsen A.B., Brenner H. Cost-effectiveness of colorectal cancer screening - An overview. Best Pract Res Clin Gastroenterol 2010, 24:439-449.
257. López Bastida J. Análisis coste-efectividad del cribado del cáncer colorrectal en la población general. Santa Cruz de Tenerife: Servicio Canario de la Salud, D.L., Ministerio de Sanidad y Consumo; 2010 (Serie: Informes de Evaluación de Tecnologías Sanitarias. SESCS;2006/23). [consultado 16/12/2011]. Disponible en: http://www2.gobiernodecanarias.org/sanidad/scs/content/5b3b8562-1f35-11e0-964e-f5f3323ccc4d/2006_23.pdf.
258. Lansdorp-Vogelaar I., Knudsen A.B., Brenner H. Cost-effectiveness of Colorectal Cancer Screening. Epidemiol Rev 2011, 33:88-100.
259. Pignone M.P., Flitcroft K.L., Howard K., Trevena L.J., Salkeld G.P., St Jones D.J.B. Cost and cost effectiveness of full implementation of a biennial faecal occult blood test screening program for bowel cancer in Australia. MJA 2011, 194:180-185.
260. Ladabaum U., Ferrandez A., Lanas A. Cost-effectiveness of colorectal cancer screening in high-risk Spanish patient's use of a validated model to inform public policy. Cancer Epidemiol Biomarkers Prev 2010, 19:2765-2776.
261. García S., Abadía B., Durán A., Bernal E. España: Análisis del sistema sanitario. Sistemas Sanitarios en Transición 2010, 12:1-240.
262. Fernández A, Pastor A, Pérez-Segura P, Castells A, López-Bastida J, Camacho S, et al. Cribado del cáncer de colon en España. ¿Es coste eficaz? Madrid: Alianza para la prevención del cáncer de colon en España; 2011.